Head and Neck cancers (HNC) are a heterogeneous group of upper aero-digestive tract
cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of …

Simple Summary This review covers the most recent and up-to-date literature on liquid
biopsy techniques in head and neck cancer. Head and neck cancer remains a common …

Background Head and neck squamous cell carcinoma (HNSCC) remain a substantial
burden to global health. Cell-free circulating tumour DNA (ctDNA) is an emerging biomarker …

Head and neck squamous cell carcinoma (HNSCC) is a molecularly heterogeneous
disease, with a 5-year survival rate that still hovers at~ 60% despite recent advancements …

Simple Summary Head and neck cancer remains a challenging and deadly disease as it is
often identified in more advanced stages due to limitations in screening and surveillance …

In the era of 'precision medicine', liquid biopsies based on cell-free DNA (cfDNA) have
emerged as a promising tool in the oncology field. cfDNA from cancer patients is a mixture of …

Background Head and neck squamous cell carcinoma remains a substantial burden to
global health. Despite evolving therapies, 5‐year survival is< 50% and unlike in other …

Massively parallel sequencing technologies have long been used in both basic research
and clinical routine. The recent introduction of digital sequencing has made previously …

Introduction: Head and neck squamous cell carcinoma (HNSCC) is one of the most common
cancers worldwide. Due to a lack of reliable markers, HNSCC patients are usually …

Advanced cutaneous squamous cell carcinoma (cSCC) encompasses unresectable and
metastatic disease. Although immune checkpoint inhibition has been approved for this entity …